Enfortumab vedotin with or without pembrolizumab offers disease control benefits for patients with upper tract urothelial cancer, said Evangelia Vlachou, MD, of Johns Hopkins Medicine.
Cycling Weekly on MSN9h
Cycling and your pelvic floor: What every rider needs to knowCycling is an incredible sport with numerous health benefits, but spending long hours in the saddle can take a toll on an ...
Patient perceptions about their treatment for muscle-invasive bladder cancer (MIBC) over the last decade. Dr. Chowdhury began his presentation by emphasizing that muscle-invasive bladder cancer (MIBC) ...
An important unanswered question is whether rechallenging patients with enfortumab vedotin plus pembrolizumab after prior ICI exposure remains effective. The authors hypothesized that enfortumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback